Annual Book Value
$163.82 M
+$12.01 M+7.91%
December 1, 2023
Summary
- As of February 7, 2025, ORMP annual book value is $163.82 million, with the most recent change of +$12.01 million (+7.91%) on December 1, 2023.
- ORMP annual book value is now -1.58% below its all-time high of $166.45 million, reached on December 1, 2021.
Performance
ORMP Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Book Value
$156.44 M
-$20.62 M-11.65%
September 1, 2024
Summary
- As of February 7, 2025, ORMP quarterly book value is $156.44 million, with the most recent change of -$20.62 million (-11.65%) on September 1, 2024.
- Over the past year, ORMP quarterly book value has dropped by -$7.38 million (-4.50%).
- ORMP quarterly book value is now -11.65% below its all-time high of $177.06 million, reached on June 1, 2024.
Performance
ORMP Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
ORMP Book Value Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +7.9% | -4.5% |
3 y3 years | - | +1.8% |
5 y5 years | +744.7% | +706.7% |
ORMP Book Value Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -1.6% | +7.9% | -11.7% | +4.9% |
5 y | 5-year | -1.6% | +744.7% | -11.7% | +872.3% |
alltime | all time | -1.6% | >+9999.0% | -11.7% | >+9999.0% |
Oramed Pharmaceuticals Book Value History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $156.44 M(-11.6%) |
Jun 2024 | - | $177.06 M(+6.3%) |
Mar 2024 | - | $166.64 M(+1.7%) |
Dec 2023 | $163.82 M(+7.9%) | $163.82 M(+9.8%) |
Sep 2023 | - | $149.13 M(-1.6%) |
Jun 2023 | - | $151.55 M(+0.4%) |
Mar 2023 | - | $150.97 M(-0.6%) |
Dec 2022 | $151.81 M(-8.8%) | $151.81 M(-1.3%) |
Sep 2022 | - | $153.81 M(+0.1%) |
Jun 2022 | - | $153.70 M(-5.3%) |
Mar 2022 | - | $162.35 M(-4.6%) |
Dec 2021 | $166.45 M(+43.8%) | - |
Nov 2021 | - | $170.16 M(+47.0%) |
Aug 2021 | $115.77 M(+252.1%) | $115.77 M(+70.0%) |
May 2021 | - | $68.12 M(+37.8%) |
Feb 2021 | - | $49.44 M(+75.3%) |
Nov 2020 | - | $28.21 M(-14.2%) |
Aug 2020 | $32.88 M(+69.5%) | $32.88 M(-3.6%) |
May 2020 | - | $34.11 M(+112.0%) |
Feb 2020 | - | $16.09 M(-6.2%) |
Nov 2019 | - | $17.16 M(-11.5%) |
Aug 2019 | $19.39 M(-37.7%) | $19.39 M(-10.0%) |
May 2019 | - | $21.56 M(-15.0%) |
Feb 2019 | - | $25.35 M(-12.2%) |
Nov 2018 | - | $28.86 M(-7.2%) |
Aug 2018 | $31.11 M(+61.7%) | $31.11 M(+86.8%) |
May 2018 | - | $16.66 M(-18.7%) |
Feb 2018 | - | $20.48 M(-9.9%) |
Nov 2017 | - | $22.74 M(+18.2%) |
Aug 2017 | $19.24 M(-26.5%) | $19.24 M(-2.9%) |
May 2017 | - | $19.81 M(-7.1%) |
Feb 2017 | - | $21.32 M(-11.1%) |
Nov 2016 | - | $23.99 M(-8.4%) |
Aug 2016 | $26.19 M(+5.5%) | $26.19 M(-15.5%) |
May 2016 | - | $30.98 M(-5.3%) |
Feb 2016 | - | $32.70 M(+45.1%) |
Nov 2015 | - | $22.54 M(-9.2%) |
Aug 2015 | $24.83 M | $24.83 M(+16.4%) |
May 2015 | - | $21.33 M(-4.5%) |
Date | Annual | Quarterly |
---|---|---|
Feb 2015 | - | $22.34 M(-5.7%) |
Nov 2014 | - | $23.70 M(+14.0%) |
Aug 2014 | $20.79 M(+155.7%) | $20.79 M(-5.4%) |
May 2014 | - | $21.97 M(-5.8%) |
Feb 2014 | - | $23.33 M(+219.3%) |
Nov 2013 | - | $7.31 M(-10.2%) |
Aug 2013 | $8.13 M(+115.2%) | $8.13 M(+95.5%) |
May 2013 | - | $4.16 M(-20.7%) |
Feb 2013 | - | $5.25 M(-16.0%) |
Nov 2012 | - | $6.25 M(+65.4%) |
Aug 2012 | $3.78 M(+1.5%) | $3.78 M(+91.6%) |
May 2012 | - | $1.97 M(-17.8%) |
Feb 2012 | - | $2.40 M(-27.7%) |
Nov 2011 | - | $3.32 M(-10.9%) |
Aug 2011 | $3.72 M(+348.5%) | $3.72 M(-16.2%) |
May 2011 | - | $4.44 M(+40.4%) |
Feb 2011 | - | $3.16 M(+288.7%) |
Nov 2010 | - | $814.10 K(-2.0%) |
Aug 2010 | $830.30 K(-69.8%) | $830.30 K(-50.6%) |
May 2010 | - | $1.68 M(-19.8%) |
Feb 2010 | - | $2.10 M(-12.6%) |
Nov 2009 | - | $2.40 M(-12.5%) |
Aug 2009 | $2.75 M(-40.2%) | $2.75 M(-4.4%) |
May 2009 | - | $2.87 M(-9.4%) |
Feb 2009 | - | $3.17 M(-13.4%) |
Nov 2008 | - | $3.66 M(-20.3%) |
Aug 2008 | $4.59 M(+795.3%) | $4.59 M(+894.2%) |
May 2008 | - | $462.00 K(+21.6%) |
Feb 2008 | - | $380.00 K(-43.4%) |
Nov 2007 | - | $671.00 K(+30.8%) |
Aug 2007 | $513.00 K(-218.6%) | $513.00 K(-166.1%) |
May 2007 | - | -$775.70 K(+33.2%) |
Feb 2007 | - | -$582.50 K(+17.6%) |
Nov 2006 | - | -$495.40 K(+14.5%) |
Aug 2006 | -$432.70 K(+865.8%) | -$432.70 K(+142.7%) |
May 2006 | - | -$178.30 K(+246.9%) |
Feb 2006 | - | -$51.40 K(+3.2%) |
Nov 2005 | - | -$49.80 K |
Aug 2005 | -$44.80 K | - |
FAQ
- What is Oramed Pharmaceuticals annual book value?
- What is the all time high annual book value for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals annual book value year-on-year change?
- What is Oramed Pharmaceuticals quarterly book value?
- What is the all time high quarterly book value for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals quarterly book value year-on-year change?
What is Oramed Pharmaceuticals annual book value?
The current annual book value of ORMP is $163.82 M
What is the all time high annual book value for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high annual book value is $166.45 M
What is Oramed Pharmaceuticals annual book value year-on-year change?
Over the past year, ORMP annual book value has changed by +$12.01 M (+7.91%)
What is Oramed Pharmaceuticals quarterly book value?
The current quarterly book value of ORMP is $156.44 M
What is the all time high quarterly book value for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high quarterly book value is $177.06 M
What is Oramed Pharmaceuticals quarterly book value year-on-year change?
Over the past year, ORMP quarterly book value has changed by -$7.38 M (-4.50%)